» Articles » PMID: 31962072

Cell Junction Proteins: Crossing the Glomerular Filtration Barrier in Diabetic Nephropathy

Overview
Publisher Elsevier
Date 2020 Jan 22
PMID 31962072
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic nephropathy as a deleterious complication of diabetes mellitus and an important cause of end-stage renal failure is characterized by changes in the molecular and cellular levels. Cell-cell communication via the gap and tight junctions are involved in the pathogenesis of diseases such as diabetes and kidney failure. Studying cell junctions including gap junctions, tight junctions, and anchoring junctions within the nephron can be used as an early sign of diabetic nephropathy. Furthermore, cell junctions may be an upcoming target by pharmacological methods to improve treatments of diabetic nephropathy and pave the way to introduce promising therapeutic strategies based on cell-cell communications effects and its translation into clinical studies for the treatment of diabetic nephropathy.

Citing Articles

Association of urinary and blood lead concentrations with all-cause mortality in US adults with chronic kidney disease: a prospective cohort study.

Li L, Zhao J Sci Rep. 2024; 14(1):23230.

PMID: 39369036 PMC: 11455948. DOI: 10.1038/s41598-024-73724-x.


The role of intercellular communication in diabetic nephropathy.

Wang B, Xiong Y, Deng X, Wang Y, Gong S, Yang S Front Immunol. 2024; 15:1423784.

PMID: 39238645 PMC: 11374600. DOI: 10.3389/fimmu.2024.1423784.


Autophagy, Pyroptosis and Ferroptosis are Rising Stars in the Pathogenesis of Diabetic Nephropathy.

Li X, Gao L, Li X, Xia J, Pan Y, Bai C Diabetes Metab Syndr Obes. 2024; 17:1289-1299.

PMID: 38505538 PMC: 10949337. DOI: 10.2147/DMSO.S450695.


Cellular junction dynamics and Alzheimer's disease: a comprehensive review.

Asghari K, Niknam Z, Mohammadpour-Asl S, Chodari L Mol Biol Rep. 2024; 51(1):273.

PMID: 38302794 DOI: 10.1007/s11033-024-09242-w.


The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.

Curran C, Kopp J J Transl Med. 2023; 21(1):706.

PMID: 37814337 PMC: 10563221. DOI: 10.1186/s12967-023-04584-8.